COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies

BACKGROUND: Disease-modifying therapies (DMTs) for multiple sclerosis (MS) target immunity and have the potential to increase the risk of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and alter its clinical course. We assessed these risks in patients with MS (PwMS). OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Reder, Anthony T., Centonze, Diego, Naylor, Maria L., Nagpal, Anjali, Rajbhandari, Rajani, Altincatal, Arman, Kim, Michelle, Berdofe, Aaron, Radhakrishnan, Maha, Jung, Eunice, Sandrock, Alfred W., Smirnakis, Karen, Popescu, Catrinel, de Moor, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980129/
https://www.ncbi.nlm.nih.gov/pubmed/33743151
http://dx.doi.org/10.1007/s40263-021-00804-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980129/
https://www.ncbi.nlm.nih.gov/pubmed/33743151
http://dx.doi.org/10.1007/s40263-021-00804-1

Ejemplares similares